Highlights – 2nd Quarter 2010
Total revenues increase 16% to record EUR 2.2 billion
Profit after tax jumps 70% to EUR 187 million
Free cash flow improves to EUR 356 from EUR 79 million
Rebif® sales +4.0% to EUR 402 million
Erbitux® sales +23% to a record EUR 210 million
Liquid Crystals revenues up 50% to a record EUR 284 million
Guidance raised for 2010: operating result incl. Millipore +90%
Millipore acquisition completed on July 14
Total revenues
Operating result
by quarterEUR million
Total revenues by quarter (bar chart)

SERVICES

DOWNLOADS

Download PDF (2.7 MB) Download XLS (0.1 MB)

ANNUAL REPORT 2009

Read the Annual Report online
 
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2010/07/29